finance.yahoo.comKaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officerover 1 year ago
businesswire.comKaliVir Immunotherapeutics Appoints Schond Greenway as Chief Financial Officerover 1 year ago
finance.yahoo.comAvalo Reports Second Quarter 2024 Financial Results and Provides Business Updatesover 1 year ago
benzinga.comAvalo Therapeutics Announces Appointment of Dr. Mittie Doyle as Chief Medical Officerover 1 year ago
benzinga.comAvalo Therapeutics Announces Appointment of Paul Varki as Chief Legal Officerover 1 year ago
finance.yahoo.comAvalo Reports First Quarter 2024 Financial Results and Provides Business Updatesalmost 2 years ago
benzinga.comAvalo Therapeutics' Newly Acquired Ex-Eli Lilly Drug Could Stand Out In Competitive Hidradenitis Suppurativa Market, Analyst Upgradesalmost 2 years ago
CashuAvalo Therapeutics: Key Updates and Developments in Recent Performance and Strategy.5 months ago